Migraine Prophylaxis

Migraine prophylaxis means taking medicine every day not to stop an attack in progress, but to make attacks less frequent, shorter, and milder. It is usually considered when migraines occur more than three or four times a month, last a long time, or respond poorly to acute treatment. Across Southeast Asia, where heat, irregular sleep, and long working hours are well-recognised triggers, preventive treatment can make a substantial difference to daily functioning.

Medicines used to treat Migraine Prophylaxis

Inderal

Propranolol

10 · 20 · 40 · 80mg

Designed to support heart rhythm and mitigate blood pressure indicated to target migraine frequency.

From $0.34 / tablet View

Catapres

Clonidine

100mcg

Formulated to mitigate high blood pressure and designed to alleviate symptoms of hypertensive and vascular states.

From $1.00 / tablet View

Inderal La

Propranolol

40mg

Indicated to manage cardiovascular stress and anxiety symptoms by antagonizing beta-adrenergic receptors.

From $0.76 / tablet View

Elavil

Amitriptyline

10 · 25 · 50mg

Designed for effective depressive symptoms management and utilized to support mood stability in patients.

From $0.37 / tablet View

Topamax

Topiramate

25 · 50 · 100mg

Designed to support the management of epilepsy and migraine, this therapeutic agent is indicated to alleviate seizure frequency and headache severity.

From $0.68 / tablet View

Sibelium

Flunarizine

5 · 10mg

Utilized to alleviate migraine symptoms by blocking calcium influx.

From $0.60 / tablet View

Valparin

Valproic Acid

250 · 500 · 750mg

Utilized to manage seizures and stabilize mood, formulated to target neurological hyperexcitability and support better physiological function in patients.

From $3.06 / tablet View

Depakene

Valproic Acid

250 · 750mg

Formulated to manage epilepsy and bipolar disorder, this medication is indicated to support the control of seizures and is utilized to mitigate mood fluctuations.

From $2.13 / capsule View

How preventive medicines work

Preventive agents act on different biological pathways, so the choice depends on a person’s broader health picture. Beta-blockers such as propranolol reduce the excitability of pain pathways and are among the best-studied options. Anticonvulsants including valproic acid and topiramate stabilise neuronal membranes and have good evidence for cutting attack days per month. The tricyclic amitriptyline is often favoured when migraine coexists with poor sleep or low mood. Flunarizine, a calcium-channel blocker widely used across Asia, is particularly popular in countries such as Thailand, the Philippines, and Indonesia where it has a long clinical track record. Clonidine is a further option in some regional formularies. All preventive medicines need several weeks to show their full effect, and the choice is typically reviewed at three months.

Who benefits and what to expect

Candidates are people whose migraines significantly disrupt work or study, those using acute relief medicines on more than ten days a month (which carries its own risks), and anyone with certain migraine subtypes such as hemiplegic migraine. Success is usually defined as a 50 per cent or greater reduction in monthly attack frequency rather than complete freedom from headache. A neurology referral is worth considering if attacks remain difficult to control, or if there are cardiovascular factors that influence medicine choice, since several agents also have a role in heart and blood pressure conditions.